Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1 - PubMed (original) (raw)
Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1
P G Speck et al. J Virol. 1991 Aug.
Abstract
Mutants of herpes simplex virus (HSV) have been used to show that a variety of key genes associated with initiation of lytic infection or replication of viral DNA are not essential for establishment of latency. These observations are extended in the present study, in which a virulent strain of HSV type 1 that is not compromised in its ability to productively infect neurons under favorable conditions was used to demonstrate early divergence of molecular pathways leading to productive and latent infection. Our experimental strategy made unique use of the segmental innervation of the vertebrate trunk to study the spread of virus throughout the peripheral nervous system after inoculation of mouse flanks. Evidence of viral gene expression, including that of immediate-early genes, was transient, confined to ganglia directly innervating the inoculated skin (8th through 12th thoracic segments), and seen only at sites from which infectious virus could be recovered. In contrast, neurons containing latency-associated transcripts and reactivatable virus were more widely distributed (sixth thoracic through first lumbar segments), from which we conclude that replication-competent HSV type 1 can establish latency without initiating productive infection.
Similar articles
- Neuronal control of herpes simplex virus latency.
Tenser RB, Edris WA, Hay KA. Tenser RB, et al. Virology. 1993 Aug;195(2):337-47. doi: 10.1006/viro.1993.1384. Virology. 1993. PMID: 8393231 - Herpes simplex virus latency in the nervous system--a new model.
Steiner I, Kennedy PG. Steiner I, et al. Neuropathol Appl Neurobiol. 1991 Dec;17(6):433-40. doi: 10.1111/j.1365-2990.1991.tb00747.x. Neuropathol Appl Neurobiol. 1991. PMID: 1666173 Review. - Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation.
Fraser NW, Valyi-Nagy T. Fraser NW, et al. Microb Pathog. 1993 Aug;15(2):83-91. doi: 10.1006/mpat.1993.1059. Microb Pathog. 1993. PMID: 8255209 Review. No abstract available.
Cited by
- An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections.
Sharma D, Sharma S, Akojwar N, Dondulkar A, Yenorkar N, Pandita D, Prasad SK, Dhobi M. Sharma D, et al. Vaccines (Basel). 2023 Jan 17;11(2):206. doi: 10.3390/vaccines11020206. Vaccines (Basel). 2023. PMID: 36851084 Free PMC article. Review. - DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals.
Dochnal S, Merchant HY, Schinlever AR, Babnis A, Depledge DP, Wilson AC, Cliffe AR. Dochnal S, et al. J Virol. 2022 Jun 22;96(12):e0050822. doi: 10.1128/jvi.00508-22. Epub 2022 May 24. J Virol. 2022. PMID: 35608347 Free PMC article. - Injection with Toxoplasma gondii protein affects neuron health and survival.
Mendez OA, Flores Machado E, Lu J, Koshy AA. Mendez OA, et al. Elife. 2021 Jun 9;10:e67681. doi: 10.7554/eLife.67681. Elife. 2021. PMID: 34106047 Free PMC article. - Herpes Simplex Virus Latency Is Noisier the Closer We Look.
Singh N, Tscharke DC. Singh N, et al. J Virol. 2020 Jan 31;94(4):e01701-19. doi: 10.1128/JVI.01701-19. Print 2020 Jan 31. J Virol. 2020. PMID: 31776275 Free PMC article. Review. - Attenuated infectious laryngotracheitis virus vaccines differ in their capacity to establish latency in the trigeminal ganglia of specific pathogen free chickens following eye drop inoculation.
Thilakarathne DS, Coppo MJC, Hartley CA, Diaz-Méndez A, Quinteros JA, Fakhri O, Vaz PK, Devlin JM. Thilakarathne DS, et al. PLoS One. 2019 Mar 28;14(3):e0213866. doi: 10.1371/journal.pone.0213866. eCollection 2019. PLoS One. 2019. PMID: 30921344 Free PMC article.
References
- Virology. 1957 Dec;4(3):435-57 - PubMed
- J Gen Virol. 1975 Sep;28(3):341-53 - PubMed
- J Virol. 1986 Feb;57(2):446-55 - PubMed
- Histopathology. 1987 Jan;11(1):93-101 - PubMed
- Brain Res. 1987 Oct 6;422(2):242-56 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical